Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 48

Similar articles for PubMed (Select 16025114)

1.

Plk4 haploinsufficiency causes mitotic infidelity and carcinogenesis.

Ko MA, Rosario CO, Hudson JW, Kulkarni S, Pollett A, Dennis JW, Swallow CJ.

Nat Genet. 2005 Aug;37(8):883-8. Epub 2005 Jul 17.

PMID:
16025114
2.

Common variants spanning PLK4 are associated with mitotic-origin aneuploidy in human embryos.

McCoy RC, Demko Z, Ryan A, Banjevic M, Hill M, Sigurjonsson S, Rabinowitz M, Fraser HB, Petrov DA.

Science. 2015 Apr 10;348(6231):235-8. doi: 10.1126/science.aaa3337.

PMID:
25859044
3.

Partial Hepatectomy in Acetylation-Deficient BubR1 Mice Corroborates that Chromosome Missegregation Initiates Tumorigenesis.

Lee YK, Park I, Lee H.

Endocrinol Metab (Seoul). 2014 Dec 29;29(4):561-6. doi: 10.3803/EnM.2014.29.4.561.

4.

A novel role for Plk4 in regulating cell spreading and motility.

Rosario CO, Kazazian K, Zih FS, Brashavitskaya O, Haffani Y, Xu RS, George A, Dennis JW, Swallow CJ.

Oncogene. 2015 Jun;34(26):3441-51. doi: 10.1038/onc.2014.275. Epub 2014 Sep 1.

PMID:
25174401
5.

PLK4 overexpression and its effect on centrosome regulation and chromosome stability in human gastric cancer.

Shinmura K, Kurabe N, Goto M, Yamada H, Natsume H, Konno H, Sugimura H.

Mol Biol Rep. 2014 Oct;41(10):6635-44. doi: 10.1007/s11033-014-3546-2. Epub 2014 Jul 1.

PMID:
24981932
6.

The Discovery of Polo-Like Kinase 4 Inhibitors: Design and Optimization of Spiro[cyclopropane-1,3'[3H]indol]-2'(1'H)-ones as Orally Bioavailable Antitumor Agents.

Sampson PB, Liu Y, Patel NK, Feher M, Forrest B, Li SW, Edwards L, Laufer R, Lang Y, Ban F, Awrey DE, Mao G, Plotnikova O, Leung G, Hodgson R, Mason J, Wei X, Kiarash R, Green E, Qiu W, Chirgadze NY, Mak TW, Pan G, Pauls HW.

J Med Chem. 2014 Jun 24. [Epub ahead of print]

PMID:
24867164
7.

p53-Dependent and cell specific epigenetic regulation of the polo-like kinases under oxidative stress.

Ward A, Hudson JW.

PLoS One. 2014 Jan 31;9(1):e87918. doi: 10.1371/journal.pone.0087918. eCollection 2014.

8.

Male hypogonadism and germ cell loss caused by a mutation in Polo-like kinase 4.

Harris RM, Weiss J, Jameson JL.

Endocrinology. 2011 Oct;152(10):3975-85. doi: 10.1210/en.2011-1106. Epub 2011 Jul 26.

9.

The HPV-16 E7 oncoprotein induces centriole multiplication through deregulation of Polo-like kinase 4 expression.

Korzeniewski N, Treat B, Duensing S.

Mol Cancer. 2011 May 24;10:61. doi: 10.1186/1476-4598-10-61.

10.

Aberrant methylation of Polo-like kinase CpG islands in Plk4 heterozygous mice.

Ward A, Morettin A, Shum D, Hudson JW.

BMC Cancer. 2011 Feb 15;11:71. doi: 10.1186/1471-2407-11-71.

11.

Polo-like kinase 4: the odd one out of the family.

Sillibourne JE, Bornens M.

Cell Div. 2010 Sep 29;5:25. doi: 10.1186/1747-1028-5-25.

12.

Plk4 is required for cytokinesis and maintenance of chromosomal stability.

Rosario CO, Ko MA, Haffani YZ, Gladdy RA, Paderova J, Pollett A, Squire JA, Dennis JW, Swallow CJ.

Proc Natl Acad Sci U S A. 2010 Apr 13;107(15):6888-93. doi: 10.1073/pnas.0910941107. Epub 2010 Mar 26.

13.

Gene expression patterns in heterozygous Plk4 murine embryonic fibroblasts.

Morettin A, Ward A, Nantais J, Hudson JW.

BMC Genomics. 2009 Jul 16;10:319. doi: 10.1186/1471-2164-10-319.

14.

Expression of a mutant p53 results in an age-related demographic shift in spontaneous lung tumor formation in transgenic mice.

Duan W, Gao L, Wu X, Hade EM, Gao JX, Ding H, Barsky SH, Otterson GA, Villalona-Calero MA.

PLoS One. 2009;4(5):e5563. doi: 10.1371/journal.pone.0005563. Epub 2009 May 15.

15.

Depletion of BubR1 promotes premature centrosomal localization of cyclin B1 and accelerates mitotic entry.

Park SY, Kim S, Cho H, Kwon SH, Chae S, Kang D, Seong YS, Cho H.

Cell Cycle. 2009 Jun 1;8(11):1754-64. Epub 2009 Jun 4.

16.

Nip2/centrobin may be a substrate of Nek2 that is required for proper spindle assembly during mitosis in early mouse embryos.

Sonn S, Jeong Y, Rhee K.

Mol Reprod Dev. 2009 Jun;76(6):587-92. doi: 10.1002/mrd.20990.

PMID:
19117032
17.

The chromosome 3p21.3-encoded gene, LIMD1, is a critical tumor suppressor involved in human lung cancer development.

Sharp TV, Al-Attar A, Foxler DE, Ding L, de A Vallim TQ, Zhang Y, Nijmeh HS, Webb TM, Nicholson AG, Zhang Q, Kraja A, Spendlove I, Osborne J, Mardis E, Longmore GD.

Proc Natl Acad Sci U S A. 2008 Dec 16;105(50):19932-7. doi: 10.1073/pnas.0805003105. Epub 2008 Dec 5.

18.

Plk2 regulated centriole duplication is dependent on its localization to the centrioles and a functional polo-box domain.

Cizmecioglu O, Warnke S, Arnold M, Duensing S, Hoffmann I.

Cell Cycle. 2008 Nov 15;7(22):3548-55. Epub 2008 Nov 26.

19.

The R246S hot-spot p53 mutant exerts dominant-negative effects in embryonic stem cells in vitro and in vivo.

Lee MK, Sabapathy K.

J Cell Sci. 2008 Jun 1;121(Pt 11):1899-906. doi: 10.1242/jcs.022822. Epub 2008 May 13.

20.

TRAIL inactivates the mitotic checkpoint and potentiates death induced by microtubule-targeting agents in human cancer cells.

Kim M, Liao J, Dowling ML, Voong KR, Parker SE, Wang S, El-Deiry WS, Kao GD.

Cancer Res. 2008 May 1;68(9):3440-9. doi: 10.1158/0008-5472.CAN-08-0014.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk